Search research articles
Contact Us
Filters
Showing results (31-40 of 229) with videos related to
Page
of 23
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 3, 2013
Population ageing and healthcare expenditure projections: new evidence from a time to death approach
Claudia Geue, Andrew Briggs, James Lewsey, et al.
Social Science & Medicine (1982)
|
October 11, 2016
Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators
John Wildman, Peter McMeekin, Eleanor Grieve, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines
Lindsay Govan, Olivia Wu, Robert Lindsay, et al.
Journal of Manipulative and Physiological Therapeutics
|
August 15, 2006
The electromyographic activity of thoracic paraspinal muscles identified as abnormal with palpation
Gary Fryer, Tony Morris, Peter Gibbons, et al.
Health Economics
|
February 3, 2005
Parametric modelling of cost data: some simulation evidence
Andrew Briggs, Richard Nixon, Simon Dixon, et al.
The New Zealand Medical Journal
|
December 15, 2017
An osteoarthritis model of care should be a national priority for New Zealand
Jennifer Baldwin, Andrew Briggs, Warwick Bagg, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
December 5, 2009
Comparative effectiveness research through the looking glass
Adrian Levy, Brian Harrigan, Karissa Johnston, et al.
Health Economics
|
April 30, 2003
Missing... presumed at random: cost-analysis of incomplete data
Andrew Briggs, Taane Clark, Jane Wolstenholme, et al.
International Journal of Technology Assessment in Health Care
|
December 3, 2013
Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patients
Seamus Kent, Andrew Briggs, Simon Eckermann, et al.
Annals of the American Thoracic Society
|
February 25, 2014
The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence
Jonathan D Campbell, R Brett McQueen, Andrew Briggs
Page
of 23
Search research articles
Search
Showing results (31-40 of 229) with videos related to
Sort By:
Page
of 23
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 3, 2013
Population ageing and healthcare expenditure projections: new evidence from a time to death approach
Claudia Geue, Andrew Briggs, James Lewsey, et al.
Social Science & Medicine (1982)
|
October 11, 2016
Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators
John Wildman, Peter McMeekin, Eleanor Grieve, et al.
Journal of Health Economics and Outcomes Research
|
September 4, 2023
How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines
Lindsay Govan, Olivia Wu, Robert Lindsay, et al.
Journal of Manipulative and Physiological Therapeutics
|
August 15, 2006
The electromyographic activity of thoracic paraspinal muscles identified as abnormal with palpation
Gary Fryer, Tony Morris, Peter Gibbons, et al.
Health Economics
|
February 3, 2005
Parametric modelling of cost data: some simulation evidence
Andrew Briggs, Richard Nixon, Simon Dixon, et al.
The New Zealand Medical Journal
|
December 15, 2017
An osteoarthritis model of care should be a national priority for New Zealand
Jennifer Baldwin, Andrew Briggs, Warwick Bagg, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
December 5, 2009
Comparative effectiveness research through the looking glass
Adrian Levy, Brian Harrigan, Karissa Johnston, et al.
Health Economics
|
April 30, 2003
Missing... presumed at random: cost-analysis of incomplete data
Andrew Briggs, Taane Clark, Jane Wolstenholme, et al.
International Journal of Technology Assessment in Health Care
|
December 3, 2013
Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patients
Seamus Kent, Andrew Briggs, Simon Eckermann, et al.
Annals of the American Thoracic Society
|
February 25, 2014
The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence
Jonathan D Campbell, R Brett McQueen, Andrew Briggs
Page
of 23